Heart Transplantation

Reading: Heart Transplantation

(by Mario C. Deng)

Advanced heart failure is an increasing epidemiological problem wordwide. Cardiac transplantation has become the gold standard treatment in selected patients during the last 25 years and is increasingly restricted to patients at greatest risk of dying. Alternative treatments include neurohormonal blockers and mechanical support devices.

>> learn more about heart transplantation

 

New Options for Heart Transplant Rejection Monitoring
The genomics revolution ushered in by the completion of the Human Genome Project has made 
possible what was only dreamed about before-namely the ability to detect rejection of the transplanted 
heart without taking a tissue sample. Non invasive monitoring using a molecular test may become an 
alternative option to detect cardiac allograft rejection.
>> learn more
 

Reading: The Grateful Heart 
(by Candace C. Moose, RN, Heart Transplant Recipient) 
Candace received immunizations in August 2001 before traveling to Malawi, to help children 
suffering from AIDS. She fell prey to a rare and generally fatal disease. She received a heart 
transplant and decided to tell her history as an expression of her faith and gratefulness.
>> Take me to the book
 

Invasive Monitoring Attenuation through Gene Expression "IMAGE" Clinical Trial

The Invasive Monitoring Attenuation through Gene Expression (IMAGE) multicenter study is enrolling stable heart transplant recipients 12-60 months after heart transplantation. The hypothesis to be tested is that gene-expression-based (AlloMap Molecular test) monitoring is not inferior to biopsy-based monitoring. The design is 1:1-randomization to either gene-Expression based or biopsy-based monitoring strategy and follow-up for >1 year (PI: Dr. Mario C. Deng)

>> learn more

 

Advanced Heart Failure and Mechanical Circulatory Support

Reading: Mechanical Circulatory Support Therapy in Advanced Heart Failure

(by Mario C Deng & Yoshifumi Naka)

Situations in which a patient with advanced heart failure is evaluated as well as cared for before and after implantation of mechanical circulatory support devices have to be described in a complementary way by professional teams and their patients. The "Mechanical Circulatory Support Therapy in Advanced Heart Failure" book provides a state-of-the-art overview of mechanical circulatory support devices and their role in the care of patients with advanced heart failure. Evidence-based medicine perspectives of expert cardiologists, cardiac surgeons, nurses, coordinators, social workers, psychologists, physical therapists, and equally important, of our patients and their relatives, are portrayed.

>> Take me to the book

 

The Myocarditis Foundation

Myocarditis is a disease marked by inflammation and damage of the heart muscle. Although the exact incidence of myocarditis is not known, it is estimated that several thousand patients per year are diagnosed in the United States. Myocarditis usually attacks otherwise healthy people. It is believed that 5 to 20% of all cases of sudden death in young adults are due to myocarditis. There are many causes of myocarditis, including viral infections, autoimmune diseases, environmental toxins, and adverse reactions to medications. The prognosis is variable but chronic heart failure is the major long term complication. Myocarditis and the associated disorder of idiopathic dilated cardiomyopathy are the cause of approximately 45% of heart transplantation in the United States.

The Myocarditis Foundation is dedicated to providing accurate and up-to-date information to medical professionals, patients and their families, and to the scientific advancement of both the diagnosis and treatment of the disease with the goal of saving more lives.

>> Learn about Myocarditis

 

 
 

HOME ABOUT US PATIENT CARERESEARCHEDUCATIONCOLLABORATIONLINKS

This site was last updated 01/18/07